Enhancing Recovery in Early Schizophrenia

NCT02926859 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Cannabidiol as add-on
DRUG: Placebo as add-on

Sponsor

Central Institute of Mental Health, Mannheim